HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chi-Chao Chan Selected Research

Sympathetic Ophthalmia (Sympathetic Uveitis)

1/2014Classical pathology of sympathetic ophthalmia presented in a unique case.
1/2011Inflammatory cytokine and chemokine expression in sympathetic ophthalmia: a pilot study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chi-Chao Chan Research Topics

Disease

51Uveitis
01/2022 - 03/2002
45Macular Degeneration (Age-Related Maculopathy)
01/2021 - 11/2003
33Inflammation (Inflammations)
11/2020 - 03/2002
23Lymphoma (Lymphomas)
01/2020 - 01/2003
22Neoplasms (Cancer)
01/2018 - 01/2004
13Retinal Degeneration
10/2015 - 07/2004
12Intraocular Lymphoma
01/2020 - 02/2002
9Melanoma (Melanoma, Malignant)
10/2018 - 11/2003
9Infections
05/2018 - 11/2003
9Hemangioblastoma
01/2018 - 09/2005
9Autoimmune Diseases (Autoimmune Disease)
03/2016 - 08/2002
8Cataract (Cataracts)
01/2016 - 07/2002
8B-Cell Lymphoma (Lymphoma, B Cell)
03/2014 - 01/2003
6Choroidal Neovascularization
12/2013 - 01/2006
6Atrophy
05/2013 - 01/2008
5Hypoxia (Hypoxemia)
01/2020 - 01/2004
5Retinitis Pigmentosa (Pigmentary Retinopathy)
01/2018 - 01/2007
5von Hippel-Lindau Disease (von Hippel Lindau Disease)
03/2015 - 01/2007
5Retinal Detachment (Retinal Detachments)
08/2014 - 09/2004
4Fibrosis (Cirrhosis)
01/2018 - 09/2004
4Eye Diseases (Eye Disease)
01/2017 - 12/2003
4Gliosis
08/2014 - 12/2004
4Disease Progression
01/2014 - 08/2009
4Diabetic Retinopathy (Retinopathy, Diabetic)
05/2013 - 11/2003
3Oculocutaneous Albinism (Albinism, Yellow Mutant)
10/2018 - 09/2007
3Retinitis
05/2018 - 07/2006
3Posterior Uveitis
08/2015 - 08/2009
3Anterior Uveitis
04/2015 - 05/2002
3T-Cell Lymphoma (Lymphoma, T Cell)
04/2015 - 05/2008
3Geographic Atrophy
08/2012 - 11/2008
3Blindness (Hysterical Blindness)
08/2011 - 09/2004
3Retinoschisis (Retinoschisis, Juvenile)
07/2011 - 01/2010
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2010 - 07/2007
3Hypersensitivity (Allergy)
07/2004 - 09/2003
2Papilledema
01/2020 - 04/2010
2Hemorrhage
01/2018 - 08/2014
2Endophthalmitis (Ophthalmia)
01/2017 - 01/2014
2Wounds and Injuries (Trauma)
01/2016 - 01/2013
2Retinal Neovascularization
06/2014 - 12/2003
2Sympathetic Ophthalmia (Sympathetic Uveitis)
01/2014 - 01/2011
2Virus Diseases (Viral Diseases)
01/2014 - 01/2008
2Ocular Paraneoplastic Syndromes
12/2013 - 04/2013

Drug/Important Bio-Agent (IBA)

76Retinaldehyde (Retinal)IBA
01/2020 - 03/2002
24AntigensIBA
01/2017 - 03/2002
22Proteins (Proteins, Gene)FDA Link
10/2018 - 03/2002
20CytokinesIBA
11/2020 - 03/2002
12interstitial retinol-binding proteinIBA
08/2015 - 08/2002
9Interleukin-17 (Interleukin 17)IBA
11/2020 - 01/2011
9Messenger RNA (mRNA)IBA
10/2018 - 03/2002
8DNA (Deoxyribonucleic Acid)IBA
01/2014 - 11/2003
8ChemokinesIBA
11/2011 - 03/2002
7Interleukin-10 (Interleukin 10)IBA
01/2020 - 01/2003
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2014 - 01/2007
6AntibodiesIBA
01/2019 - 03/2004
6Fluorescein (Funduscein)FDA LinkGeneric
01/2018 - 02/2002
6Adrenal Cortex Hormones (Corticosteroids)IBA
06/2014 - 03/2005
6T-Cell Antigen Receptors (T-Cell Receptor)IBA
08/2013 - 09/2002
5Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
05/2016 - 01/2003
5Complement System Proteins (Complement)IBA
03/2016 - 11/2007
5EpitopesIBA
08/2015 - 04/2003
5Retinal Pigments (Pigments, Visual)IBA
01/2014 - 08/2008
5Biomarkers (Surrogate Marker)IBA
09/2011 - 06/2007
5Chemokine ReceptorsIBA
10/2004 - 03/2002
4InterleukinsIBA
01/2020 - 09/2006
4CholesterolIBA
11/2018 - 11/2005
4AutoantigensIBA
09/2011 - 07/2004
4Peptides (Polypeptides)IBA
09/2011 - 08/2002
4EndotoxinsIBA
04/2008 - 05/2002
3Therapeutic UsesIBA
01/2020 - 07/2005
3Interleukin-6 (Interleukin 6)IBA
01/2020 - 05/2016
3Monophenol Monooxygenase (Tyrosinase)IBA
10/2018 - 07/2008
3InterferonsIBA
05/2018 - 01/2008
3Biological ProductsIBA
01/2017 - 11/2003
3MicroRNAs (MicroRNA)IBA
03/2014 - 08/2012
3Rituximab (Mabthera)FDA Link
04/2013 - 05/2006
3Complement Factor H (Factor H)IBA
11/2008 - 06/2006
3Monoclonal AntibodiesIBA
11/2008 - 11/2004
3hen egg lysozymeIBA
06/2008 - 03/2002
2Oxygen (Dioxygen)IBA
01/2020 - 01/2007
2Interleukin-22 (IL-22)IBA
01/2019 - 07/2011
2nitisinone (Orfadin)FDA Link
10/2018 - 10/2011
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2018 - 03/2012
2Transcription Factors (Transcription Factor)IBA
01/2017 - 07/2005
2Indicators and Reagents (Reagents)IBA
01/2017 - 03/2016
2SteroidsIBA
05/2016 - 05/2003
2InflammasomesIBA
01/2016 - 11/2013
2Crystallins (Crystallin)IBA
01/2016 - 07/2011
2Capsules (Microcapsules)IBA
01/2016 - 11/2007
2Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
12/2015 - 03/2009
2Glycoproteins (Glycoprotein)IBA
11/2014 - 12/2008
2RNA (Ribonucleic Acid)IBA
03/2014 - 09/2006
2Anti-Bacterial Agents (Antibiotics)IBA
01/2014 - 01/2006
2Indocyanine Green (Cardio-Green)FDA LinkGeneric
12/2013 - 12/2013
2AutoantibodiesIBA
12/2013 - 11/2012

Therapy/Procedure

23Therapeutics
01/2021 - 07/2002
5Vitrectomy
09/2011 - 09/2004
4Lasers (Laser)
03/2016 - 11/2003
3Intravitreal Injections
01/2022 - 11/2006
3Drug Therapy (Chemotherapy)
02/2009 - 05/2003
2Radiotherapy
08/2014 - 06/2010